Aion Therapeutic Inc.
AION
CNSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -614.19% | -612.17% | -2,469.97% | 37.60% | 58.14% |
| Total Depreciation and Amortization | 1,556.82% | 490.91% | 137.40% | -21.68% | -81.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4,565.51% | 4,139.73% | 957.37% | -32.27% | -77.81% |
| Change in Net Operating Assets | -52.56% | -92.71% | -54.15% | -20.33% | -63.07% |
| Cash from Operations | -396.23% | -473.31% | -1,732.26% | 160.82% | -48.36% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 91.21% | -240.53% | -- | -- | -- |
| Cash from Investing | 82.07% | -420.12% | -313.46% | -240.67% | -344.92% |
| Total Debt Issued | 2,220.62% | 356.59% | -85.27% | -88.32% | -95.18% |
| Total Debt Repaid | -72.14% | 46.63% | 81.14% | 92.94% | -192.98% |
| Issuance of Common Stock | 82.86% | 346.08% | 992.50% | 442.50% | 442.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 188.99% | 626.10% | 553.12% | 140.16% | -11.33% |
| Foreign Exchange rate Adjustments | 398.40% | -69.59% | 132.92% | 67.17% | 83.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 880.90% | 180.47% | 6,387.50% | 28,888.89% | -504.55% |
